Document is current

Article History

Received: 13 December 2023

Accepted: 2 April 2024

First Online: 18 April 2024

Declarations

:

: Ethics review for the conduct of this program was provided by Adverra central review board (Protocol 69571)

: Not applicable.

: KG reports grants and/or personal fees from AstraZeneca, Covis, GSK, Novartis, Sanofi, TEVA, Valeo, Boehringer Ingelheim, and Regeneron. HK reports lecturing or attending advisory boards for ALK, AstraZeneca, Bausch Health, CSL Behring, GSK, Miravo, Novartis, Medexus, Pfizer, Sanofi, Takeda, and Valeopharma. HK is the Editor-in-Chief of Allergy, Asthma and Clinical Immunology as well as Associate Professor at Western University and Assistant Clinical Professor at McMaster University. IM reports [to be provided]. JP reports consulting fees from AstraZeneca, Ipsen, Edwards Lifesciences, RedNucleus; CKNC reports financial relationships (grants or research support, speakers fees, consulting fees) with AstraZeneca, Boehringer Ingelheim, CHIEF, Cipher, COVIS, E & Y, GSK, HRH, IC-EBM, MD-Briefcase, MeduCom, Merck, Novartis, Regeneron, Sanofi-Genzyme and acts as an inspector for CPSO.